microRNA-9 functions as a tumor suppressor in colorectal cancer by targeting CXCR4

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNA (miR) dysregulation is implicated in colorectal cancer (CRC) initiation and progression.
• miR-9 is recognized as a tumor suppressor in various cancers, but its specific role and mechanisms in CRC are not fully understood.

Purpose of the Study:

• To investigate the role of miR-9 in colorectal cancer (CRC) progression.
• To elucidate the molecular mechanisms underlying miR-9's function in CRC.

Main Methods:

• Analysis of miR-9 expression in CRC tissues versus adjacent non-tumor tissues.
• Correlation analysis of miR-9 expression with clinical parameters (TNM stage, metastasis, prognosis).
• In vitro assays (cell proliferation, migration, invasion) with ectopic miR-9 expression.
• Dual-Luciferase Reporter Assay to identify miR-9 targets.
• In vitro and in vivo (animal xenograft) experiments with CXCR4 manipulation (depletion, rescue).
• Assessment of epithelial-mesenchymal transition (EMT) markers.

Main Results:

• miR-9 expression was significantly lower in CRC tissues compared to non-tumor tissues.
• Reduced miR-9 expression correlated inversely with advanced TNM stage, lymph node metastasis, and poor prognosis in CRC patients.
• Ectopic miR-9 expression suppressed CRC cell proliferation, migration, and invasion.
• C-X-C Motif Chemokine Receptor 4 (CXCR4) was identified as a direct target of miR-9.
• miR-9's tumor-suppressive effects were mediated through targeting CXCR4, as confirmed by rescue experiments and in vivo studies.
• miR-9 overexpression or CXCR4 knockdown affected cell proliferation and EMT.

Conclusions:

• miR-9 functions as a tumor suppressor in colorectal cancer (CRC).
• miR-9 inhibits CRC progression, proliferation, migration, and invasion by directly targeting CXCR4.
• The miR-9/CXCR4 axis represents a potential therapeutic target for CRC treatment.